The new NICE Quality Standard provides a valuable framework for healthcare professionals involved in pre- and post-natal care. The new QS covers the management of diabetes and its complications in women who are planning a pregnancy and those already pregnant.
NICE has published a new diabetes quality standard for adults featuring seven new and updated statements covering type 2 diabetes prevention, structured education programmes, care and treatment, and prevention and management of foot problems. The new quality standard updates the 2011 version.
Dapagliflozin is now recommended by NICE as part of triple therapy with metformin and a sulfonylurea when two drugs for type 2 diabetes are not providing glycaemic control.
NICE have recently updated the guidance in a number of sections of the type 2 diabetes guidelines (NG28). New information on sodium–glucose cotransporter 2 (SGLT-2) inhibitors has been added to the section on initial drug treatment when metformin is contraindicated or not tolerated.
The National Institute for Health and Clinical Excellence (NICE) recommends that all people with diabetes should receive nine key tests at their annual diabetes review. These important markers ensure diabetes is well controlled and are designed to prevent longterm complications. The nine key tests are: weight, blood pressure, smoking status, HbA1c, urinary albumin, serum creatinine, cholesterol, eye examinations and foot examinations. This review discusses the importance of each marker of improved long-term care of patients.
A new wound care system using nitric oxide has been shown to heal diabetic foot ulcers faster and more effectively than standard care in UK treatment centres.
Two new studies highlight the ongoing gap in life expectancy between people living with type 1 diabetes (T1D) and the general population.
The number of people diagnosed with diabetes in the UK has more than doubled in the last twenty years, according to new analysis released today by Diabetes UK. The new figures show that there are now almost 3.7 million people living with a diagnosis of the condition in the UK, an increase of 1.9 million since 1998.
*The British Journal of Primary Care Nursing approached Abbott Healthcare Products Limited to fund the production of this supplement. The company was not involved in its development, although it was asked to review it for technical accuracy just prior to printing. Editorial control has remained with the British Journal of Primary Care Nursing at all times.